 LEXINGTON, Mass.--BUSINESS WIRE--Aldeyra Therapeutics, Inc. Nasdaq: ALDX Aldeyra today announced it will host a webcast and conference call on Tuesday, July 12, 2022, at 8:00 a.m. ET to report top-line results from the crossover clinical trial of reproxalap, an investigational new drug candidate, for the treatment of dry eye disease. The dial-in numbers are 844 200-6205 for domestic callers and 646 904-5544 for international callers. The access code is 853619. A live audio webcast o 